Core Viewpoint - The Schall Law Firm is investigating Abacus Global Management, Inc. for potential violations of securities laws, particularly concerning misleading statements and undisclosed information [1][2]. Group 1: Investigation Details - The investigation centers on whether Abacus issued false or misleading statements and failed to disclose critical information to investors [2]. - A report by Morpheus Research claims that Abacus changed its portfolio valuation methodology to present a more favorable financial picture, suggesting that the company is involved in an accounting scheme related to life settlements [2]. Group 2: Company Background - Abacus Global Management is identified as a SPAC (Special Purpose Acquisition Company) with a valuation of $794 million [2]. - The report also raises concerns about the methodologies used by Abacus to estimate life expectancy, indicating potential irregularities in their calculations [2]. Group 3: Legal Representation - The Schall Law Firm is reaching out to shareholders who may have suffered losses and is offering free consultations regarding their rights [3].

Core Viewpoint - Safe & Green Holdings Corp. has engaged Shareholder Intelligence Services, LLC to investigate potential illegal trading activities, including naked short selling and market manipulation of its common stock [1][2]. Group 1: Company Actions - The decision to engage ShareIntel follows an internal review that raised concerns about potential violations of securities laws [2]. - The company aims to utilize ShareIntel's DRIL-Down™ analytics to gain insights into shareholder trading activity and protect investor interests [2][3]. - The company is also considering further legal and regulatory actions, including participation in the SEC Whistleblower Program and collaboration with other affected public companies [3]. Group 2: Shareholder Intelligence Services - ShareIntel is an application service provider that helps public companies track and analyze shareholder trading information [4]. - The patented DRIL-Down™ process will be used to aggregate and analyze data from various sources, enabling the company to identify suspicious trading activities [4]. Group 3: Company Overview - Safe & Green Holdings Corp. specializes in the development, design, and fabrication of modular structures, focusing on sustainable solutions across various industries [5]. - The company supports developers, architects, builders, and owners in achieving faster execution and greener construction [5].

Group 1 - Halper Sadeh LLC is investigating TuHURA Biosciences, Inc. (NASDAQ: HURA) for potential violations related to its merger with Kineta, Inc. [1] - Vigil Neuroscience, Inc. (NASDAQ: VIGL) is under scrutiny due to its sale to Sanofi, where shareholders will receive $8.00 per share in cash and a contingent value right for an additional $2.00 per share based on the commercial sale of VG-3927 [1] - The firm may seek increased consideration for shareholders and additional disclosures regarding the proposed transactions [2] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options at no cost [3] - The firm represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [3]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Organon & Co. regarding a class action lawsuit due to alleged misleading statements and concealment of material facts related to the company's capital allocation and dividend strategy [1][3]. Group 1: Allegations and Impact - The allegations state that Organon provided overly positive statements to investors while concealing adverse facts about its priorities, particularly regarding capital allocation and a debt reduction strategy following the acquisition of Dermavant [3]. - As a result of these actions, Organon reduced its regular quarterly dividend by 70%, leading to a significant decline in stock price from $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025, representing a drop of over 27% in just one day [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as October 31, 2024, to April 30, 2025, and shareholders are encouraged to register for participation in the class action [3][4]. - The deadline for shareholders to seek lead plaintiff status is July 22, 2025, and there is no cost or obligation for participation [4]. Group 3: Law Firm's Commitment - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that artificially inflated stock prices [5].

Core Viewpoint - Treace Medical Concepts, Inc. (NASDAQ: TMCI) is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its primary product, the 3D bunion correction system, "Lapiplasty" [3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from May 8, 2023, to May 7, 2024 [3]. - Allegations include that competition negatively impacted the demand for the Lapiplasty system, leading to a decline in Treace Medical's revenue [3]. - The company needed to accelerate plans for an alternative product to osteotomy due to these challenges [3]. - Defendants' positive statements about the company's business and prospects were claimed to be materially misleading [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by June 10, 2025, to participate in potential recovery [4]. - Registration will include enrollment in a portfolio monitoring software for status updates throughout the case [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Napco Security Technologies, Inc. regarding a class action lawsuit due to alleged misleading statements about the company's growth and hardware sales performance [1][2]. Summary by Relevant Sections Allegations - The complaint alleges that Napco's management provided investors with optimistic projections about the company's growth and strength in its hardware division, claiming confidence in achieving fiscal 2026 growth targets based on demand forecasts [1]. - On February 3, 2025, Napco reported a significant decline in hardware sales, attributing this primarily to reduced sales from two major distributors, leading to a retraction of their long-term 45% EBITDA margin target [1]. Stock Performance - Following the announcement of disappointing financial results, Napco's stock price fell from $36.70 per share on January 31, 2024, to $26.93 per share on February 3, 2025, marking a decline of approximately 26.62% in one day [1]. Class Action Details - Shareholders who purchased shares during the specified class period (February 5, 2024, to February 3, 2025) are encouraged to register for the class action, with a deadline for lead plaintiff applications set for June 24, 2025 [2]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case's progress [2]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud, aiming to hold companies accountable for misleading practices that inflate stock prices [3].

Core Viewpoint - A class action lawsuit has been filed against Napco Security Technologies, Inc. for alleged violations of federal securities laws, particularly concerning misleading statements about growth projections and sales performance [1][2]. Group 1: Lawsuit Details - The lawsuit pertains to shareholders who purchased Napco's securities between February 5, 2024, and February 3, 2025 [1]. - The complaint claims that Napco made false statements regarding its confidence in growth projections based on customer demand for hardware products [2]. - Napco's financial results for the second quarter, announced on February 3, 2025, showed a decline in hardware product sales, contradicting previous optimistic statements [2]. Group 2: Financial Performance - The company attributed the sales shortfall to reduced sales from two of its larger distributors [2]. - Following the disappointing sales results, Napco retracted its long-term EBITDA margin target of 45%, stating uncertainty about its achievability [2].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Strategy Incorporated (NASDAQ: MSTR) about a class action lawsuit due to alleged misleading statements regarding the company's bitcoin investment strategy and treasury operations [1][2]. Group 1: Allegations - The complaint claims that during the class period from April 30, 2024, to April 4, 2025, the defendants made materially false and misleading statements [2]. - It is alleged that the anticipated profitability of the company's bitcoin-focused investment strategy was overstated [2]. - The risks associated with bitcoin's volatility and potential losses from digital assets were understated, leading to misleading public statements [2]. Group 2: Class Action Details - The deadline for shareholders to register for the class action is July 15, 2025 [3]. - Shareholders who register will be enrolled in a portfolio monitoring software for status updates throughout the case [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors affected by deceit and illegal business practices [4]. - The firm is committed to ensuring companies adhere to responsible business practices and good corporate citizenship [4]. - The firm seeks recovery for investors who suffered losses due to false or misleading statements that inflated the company's stock [4].

URGN Investors with Losses Encouraged to Contact Hagens BermanSAN FRANCISCO, May 29, 2025 /PRNewswire/ -- On May 21, 2025, investors in UroGen Pharma Ltd. (NASDAQ: URGN) saw the price of their shares crash 44% after the company announced that the FDA's Oncologic Drugs Advisory Committee ("ODAC") voted against the risk/benefit profile of UroGen's UGN-102, a therapy intended to treat patients with low-grade, intermediate-risk non-muscle invasive bladder cancer ("LG-IR-NMIBC") for which no drugs are currently ...

Core Points - The Gross Law Firm has issued a notice to shareholders of Ibotta, Inc. regarding a class action lawsuit related to the company's initial public offering on April 18, 2024 [1][3] - The lawsuit alleges that Ibotta made false statements and failed to disclose the risks associated with its contract with Kroger, specifically that the contract was at-will and could be terminated without warning [4] - Shareholders are encouraged to register for the class action by June 16, 2025, to potentially become lead plaintiffs and receive updates on the case [5] Company and Industry Summary - Ibotta, Inc. is facing legal challenges due to allegations of misleading investors about the nature of its contract with Kroger, which could impact investor confidence and stock performance [4] - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to misleading statements from companies like Ibotta [6]